Transcendent Capital Group’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,638
Closed -$38.4K 225
2024
Q4
$38.4K Buy
1,638
+1,325
+423% +$31.4K 0.02% 218
2024
Q3
$7.54K Buy
+313
New +$7.47K ﹤0.01% 380

Other funds holding IBD

Transcendent Capital Group's IBD Position: Q1 2025 in Review

Transcendent Capital Group sold out of Inspire Corporate Bond ETF (IBD) in Q1 2025, closing a stake of 1,638 shares — an estimated $38.4K sold.

Transcendent Capital Group first reported a position in IBD in Q3 2024 and held it in 2 quarters. The position peaked at $38.4K in Q4 2024. 92 funds tracked by Wall St. Rank hold IBD as of Q1 2025.

  • Transcendent Capital Group reported no remaining Inspire Corporate Bond ETF position as of Q1 2025 after selling out during the quarter.
  • Transcendent Capital Group sold 1,638 Inspire Corporate Bond ETF shares in Q1 2025, an estimated $38.4K.
  • Transcendent Capital Group first reported a position in Inspire Corporate Bond ETF in Q3 2024 and held it in 2 quarters.
  • Transcendent Capital Group's Inspire Corporate Bond ETF position peaked at $38.4K in Q4 2024.
  • 92 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2025.

Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.